Lightcalls.com
 

It's useful It's bad, It doesn't d...

It's useful It's bad, It doesn't do anything. No, wait, it's worthy I think. Recent news bites about vitamin E's heart benefits--or lack thereof--may have caught your attention. moreover this latest controversy is just undivided in a history of testing the vitamin's potential.

alone a decade ago, vitamin E was commended for almost everyone, especially to improve heart health. Popular studies reported in 1995 in the Annals of Internal Medicine indicated that taking vitamin E for pair or more years significantly reduc the risk of heart disease.

nevertheless in 2001, studies declaring that vitamin E was neither pious nor bad appeared in several publications. A major review of 84 trials in The Lancet in June 2003 conclud that E didn't decrease the risk of death from heart disease or blow Then, in the July 2004 Annals of Internal Medicine, researchers rest that vitamin E had no clinical issues on cardiovascular disease.

As if that weren't discouraging enough, a January 2005 issue of the Annals of Internal Medicine included a John Hopkins research suggesting that high-dose vitamin E (400IU or more) actually increased the risk of mortality. However, the researchers admitted a weakness in their work; their investigation subjects already had a chronic disease, making the findings difficult to apply to healthy populations.



on the other hand wait. Even newer research involving 40000 women has set that those taking 600IU of vitamin E each other day for 10 years are 24 percent les likely to die of cardiovascular disease than those taking a placebo. However, for reasons unclear to one observers, the researchers--from Brigham and Women's Hospital and Harvard denomination of Public Health--have dismissed their have findings. In the July 6 2005 issue of the Journal of the American Medical Association, they conclud that vitamin E doesn't affect total mortality and has no overall cardiovascular benefit.

on the contrary this conclusion isn't shared by way of all. "This study is actual exciting and very important," says Maret Traber, PhD instructor of nutrition at the Linus Pauling Institute at Oregon State University. "It exhibit tos profound benefits of vitamin E in older women around the ages where they generally begin to come by heart disease." What's more, this research found women aged 65 and above had a 49 percent globule in cardiovascular risk, according to Traber.

however what about all the conflicting studies above the past several years? Traber's answer: "It is awfully hard, unruffled for experts, to know what to do. I wouldn't worry about taking vitamin E" In fact, she says flatly, "You ne it, especially if you have a family history of heart disease."

COPYRIGHT 2005 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2005 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.